¹³C labeled abundance testing is a specialized analytical service that quantifies the isotopic enrichment of carbon-13 in labeled compounds, biological matrices, and tracer samples. Using isotope ratio mass spectrometry (IRMS), LC-MS, and ¹³C NMR, this testing verifies labeling quality, determines atom% ¹³C enrichment, and resolves isotopologue distributions. It is essential for pharmaceutical development, metabolic flux analysis, and stable isotope tracer studies.
Technical Overview
Carbon-13 (¹³C) is a stable, non-radioactive isotope of carbon that occurs naturally at an average abundance of approximately 1.1 atom percent. In isotope labeling, synthetic or biosynthetic processes enrich specific carbon positions of a molecule with ¹³C far above this natural baseline, producing tracers that can be monitored unambiguously by mass spectrometry or NMR spectroscopy. ¹³C labeled abundance testing measures how completely and how precisely this enrichment was achieved.
Quantitative results are typically reported as atom percent ¹³C (the total fraction of carbon atoms that are ¹³C), atom percent excess (enrichment above the natural background), or as an isotopologue distribution (the relative proportions of M+0, M+1, M+2, and higher mass species). For multi-site labeled compounds, position-specific verification confirms that the label resides at the intended carbon atoms. Accurate abundance data are critical for validating synthetic routes, qualifying labeled reference materials, and interpreting metabolic tracer experiments quantitatively.
Testing Samples
¹³C-Labeled Small Molecules
Purified labeled compounds such as amino acids, glucose and other sugars, organic acids, fatty acids, nucleotides, vitamins, and metabolite standards. These samples are typically submitted as dry solids or concentrated solutions and are analyzed to confirm labeled atom percent, isotopologue purity, and chemical purity.
Pharmaceutical Intermediates and APIs
Stable isotope-labeled drug candidates, labeled internal standards for bioanalytical assays, and intermediates from ¹³C synthesis routes. Testing documents enrichment at each synthesis stage, supports batch release of labeled materials, and verifies label integrity after formulation or storage stability studies.
Biological Matrices from Tracer Experiments
Plasma, urine, tissue homogenates, cell extracts, microbial biomass, and culture media collected from in vivo or in vitro studies using ¹³C-labeled substrates. Sample preparation isolates target analytes or converts total carbon to CO₂ for bulk isotope measurement, depending on the study design.
Gaseous and Carbonate Samples
Headspace or collected CO₂, breath samples, dissolved inorganic carbon, and carbonates. These are measured to trace carbon flux in respiration studies, fermentation monitoring, and environmental carbon cycling experiments.
Plant, Food, and Environmental Samples
Plant tissues from ¹³CO₂ labeling experiments, food ingredients for authenticity verification, soils, and sediments. Bulk analysis distinguishes natural carbon isotope signatures from artificially enriched material and quantifies label incorporation into biomass.
Testing Items
Core analytical deliverables include:
- Total ¹³C isotope abundance (atom percent ¹³C) of the compound or sample
- Atom percent excess enrichment relative to the natural abundance baseline
- Isotopologue distribution (M+0 through M+n) and labeled fraction purity
- Site-specific (position-specific) enrichment verification at designated carbon atoms
- δ¹³C values reported against the VPDB international reference scale
- Unlabeled impurity assessment and dilution-corrected enrichment calculation
- Stability monitoring of label retention under storage or process conditions
Testing Methods
Elemental Analysis–Isotope Ratio Mass Spectrometry (EA-IRMS)
The reference method for bulk ¹³C abundance. The sample is combusted to CO₂, and the mass 44/45/46 ion ratio is measured with high precision on an isotope ratio mass spectrometer calibrated against international standards. Typical external precision is better than ±0.3‰ for δ¹³C, corresponding to atom percent accuracy well within ±0.1 atom percent at natural abundance and superior absolute precision at elevated enrichments.
GC-C-IRMS and LC-IRMS
Compound-specific isotope analysis couples chromatographic separation to combustion and IRMS detection. GC-C-IRMS resolves individual compounds in volatile or derivatized mixtures, while LC-IRMS handles polar, thermolabile analytes such as sugars and amino acids without derivatization, delivering compound-specific atom percent ¹³C from complex matrices.
Liquid Chromatography–Mass Spectrometry (LC-MS and HRMS)
High-resolution mass spectrometry directly resolves the isotopologue envelope of a labeled molecule, quantifying M+0 through M+n species after natural abundance correction. This approach is ideal for verifying labeled internal standards, measuring incorporation kinetics in metabolomics, and confirming labeled fraction in pharmaceutical quality control.
¹³C Nuclear Magnetic Resonance Spectroscopy
Quantitative ¹³C NMR provides position-specific information, confirming which carbon atoms carry the label and measuring enrichment at each site. It is the definitive technique for multi-site labeled compounds where positional isomers or scrambling must be excluded.
Applications
- Quality control and batch release of ¹³C-labeled compounds, internal standards, and tracers
- Verification of isotope labeling synthesis routes and label scrambling during scale-up
- Drug metabolism and ADME studies using ¹³C-labeled drug candidates
- Metabolic flux analysis and stable isotope-resolved metabolomics in cell and animal models
- Gut microbiome and fermentation research using ¹³C-labeled substrates
- Food authenticity testing and distinguishing natural from synthetic ingredients
- Environmental carbon tracing in soils, sediments, and ecosystems
- Verification of ¹³C-urea and other substrates used in breath test diagnostics
FAQ
What sample quantity is required for testing?
EA-IRMS typically requires 0.2–2 mg of carbon-containing material, while LC-MS and NMR methods may need several milligrams depending on molecular weight and enrichment level. Biological matrices are accepted in volumes of 50–500 µL or equivalent tissue masses after consultation on preparation requirements.
What enrichment range can be measured?
Methods cover the full range from natural abundance (≈1.1 atom percent ¹³C) through 99+ atom percent enriched material. Detection of enrichment as low as 0.01 atom percent excess is achievable with IRMS in tracer experiments.
How are results reported?
Reports include atom percent ¹³C, atom percent excess where applicable, isotopologue distribution profiles, δ¹³C values against VPDB, method descriptions, calibration details, and measurement uncertainty. Site-specific NMR results are reported as per-position enrichment percentages.
What is the typical turnaround time?
Standard testing is completed within 5–10 working days after sample receipt, depending on sample complexity and whether method development or matrix cleanup is required.
Why measure abundance rather than assume the labeled value?
Isotope exchange, incomplete incorporation, and purification losses can reduce actual enrichment below the nominal specification. Independent verification ensures quantitative validity of tracer calculations, regulatory compliance of labeled materials, and reproducibility of metabolic studies.
Why Choose ZKGX?
- State-of-the-art analytical equipment
- Highly qualified scientific team
- Fast turnaround time
- Competitive pricing